Digitisation | May 01, 2023
Aptar Digital Health and Healint collaborate for Central Nervous System
The partnership will capitalize on the combined capabilities of the two organizations
The partnership will capitalize on the combined capabilities of the two organizations
Cooperative agreement with U.S. Government to advance U.S. biopharma industry and ensure pandemic preparedness
Company intends to increase sales in the UK to approximately 2 million Euros by focusing on seven molecules which are already registered in the country
The business and product range of Ipca and that of Unichem complements each others business and product range
New high-tech facility in Biberach offers attractive workplaces for more than 500 scientists
Apollo continues to invest in genomics technology and research for better patient care
This is the first time the Agency has authorized the Phase 3 clinical evaluation in the U.S of a microbiota-based live biotherapeutic based on a pooling technology
The acquisition is a crucial step in LTS' strategy to broaden its portfolio of drug delivery platforms.
The acquisition would be by way of a share purchase agreement dated Dec. 26, 2022.
Prometheus Biosciences’ comprehensive data set enables target discovery and precision medicine approach in inflammation and immunology
Subscribe To Our Newsletter & Stay Updated
